These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 35820485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.
    Sontag JM, Nunbhakdi-Craig V, White CL, Halpain S, Sontag E.
    J Biol Chem; 2012 Apr 27; 287(18):14984-93. PubMed ID: 22403409
    [Abstract] [Full Text] [Related]

  • 3. Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam.
    Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K.
    Proc Natl Acad Sci U S A; 2014 Jan 21; 111(3):1144-9. PubMed ID: 24395787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Glycogen synthase kinase-3β regulates Tyr307 phosphorylation of protein phosphatase-2A via protein tyrosine phosphatase 1B but not Src.
    Yao XQ, Zhang XX, Yin YY, Liu B, Luo DJ, Liu D, Chen NN, Ni ZF, Wang X, Wang Q, Wang JZ, Liu GP.
    Biochem J; 2011 Jul 15; 437(2):335-44. PubMed ID: 21554241
    [Abstract] [Full Text] [Related]

  • 6. PTPA activates protein phosphatase-2A through reducing its phosphorylation at tyrosine-307 with upregulation of protein tyrosine phosphatase 1B.
    Luo Y, Nie YJ, Shi HR, Ni ZF, Wang Q, Wang JZ, Liu GP.
    Biochim Biophys Acta; 2013 May 15; 1833(5):1235-43. PubMed ID: 23428800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity.
    Wang Y, Liu J, Chen M, Du T, Duan C, Gao G, Yang H.
    Int J Biochem Cell Biol; 2016 Jun 15; 75():34-44. PubMed ID: 27012437
    [Abstract] [Full Text] [Related]

  • 10. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
    Xiong Y, Jing XP, Zhou XW, Wang XL, Yang Y, Sun XY, Qiu M, Cao FY, Lu YM, Liu R, Wang JZ.
    Neurobiol Aging; 2013 Mar 15; 34(3):745-56. PubMed ID: 22892311
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
    Liu R, Zhou XW, Tanila H, Bjorkdahl C, Wang JZ, Guan ZZ, Cao Y, Gustafsson JA, Winblad B, Pei JJ.
    J Cell Mol Med; 2008 Mar 15; 12(1):241-57. PubMed ID: 18208556
    [Abstract] [Full Text] [Related]

  • 12. Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy.
    Bhaskar K, Hobbs GA, Yen SH, Lee G.
    Neuropathol Appl Neurobiol; 2010 Oct 15; 36(6):462-77. PubMed ID: 20609109
    [Abstract] [Full Text] [Related]

  • 13. Src family kinases are required for integrin but not PDGFR signal transduction.
    Klinghoffer RA, Sachsenmaier C, Cooper JA, Soriano P.
    EMBO J; 1999 May 04; 18(9):2459-71. PubMed ID: 10228160
    [Abstract] [Full Text] [Related]

  • 14. Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.
    Landrieu I, Smet-Nocca C, Amniai L, Louis JV, Wieruszeski JM, Goris J, Janssens V, Lippens G.
    PLoS One; 2011 May 04; 6(6):e21521. PubMed ID: 21731772
    [Abstract] [Full Text] [Related]

  • 15. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
    Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Köhler A, Glossmann H, Schneider R, Sutherland C, Schweiger S.
    Proc Natl Acad Sci U S A; 2010 Dec 14; 107(50):21830-5. PubMed ID: 21098287
    [Abstract] [Full Text] [Related]

  • 16. Leucine carboxyl methyltransferase 1 (LCMT1)-dependent methylation regulates the association of protein phosphatase 2A and Tau protein with plasma membrane microdomains in neuroblastoma cells.
    Sontag JM, Nunbhakdi-Craig V, Sontag E.
    J Biol Chem; 2013 Sep 20; 288(38):27396-27405. PubMed ID: 23943618
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease.
    Theendakara V, Bredesen DE, Rao RV.
    Mol Cell Neurosci; 2017 Sep 20; 83():83-91. PubMed ID: 28720530
    [Abstract] [Full Text] [Related]

  • 18. Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A.
    Barisic S, Schmidt C, Walczak H, Kulms D.
    Biochem Pharmacol; 2010 Aug 15; 80(4):439-47. PubMed ID: 20450893
    [Abstract] [Full Text] [Related]

  • 19. Activation of c-Src and Fyn kinases by protein-tyrosine phosphatase RPTPalpha is substrate-specific and compatible with lipid raft localization.
    Vacaresse N, Møller B, Danielsen EM, Okada M, Sap J.
    J Biol Chem; 2008 Dec 19; 283(51):35815-24. PubMed ID: 18948260
    [Abstract] [Full Text] [Related]

  • 20. Protein Tyrosine Kinase Fyn Regulates TLR4-Elicited Responses on Mast Cells Controlling the Function of a PP2A-PKCα/β Signaling Node Leading to TNF Secretion.
    Martín-Ávila A, Medina-Tamayo J, Ibarra-Sánchez A, Vázquez-Victorio G, Castillo-Arellano JI, Hernández-Mondragón AC, Rivera J, Madera-Salcedo IK, Blank U, Macías-Silva M, González-Espinosa C.
    J Immunol; 2016 Jun 15; 196(12):5075-88. PubMed ID: 27183589
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.